Biotech · Private company · National Harbor, MD, US
Reversal Therapeutics Inc
Track this companyFree. Adds Reversal Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Investigating the safety and efficacy of pillararene sulfates as novel and effective reversal agents for both steroidal and non-steroidal neuromuscular blocking agents.Fiscal year 2025 · $368.4KNIH RePORTER 1R41GM159487-01 · fetched Nov 12, 2026